Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

This research found that the clinical outcomes (PFS, ORR, OS) of the non-platinum-based doublet regimen (docetaxel capecitabine combination) were similar to those of the platinum-based (oxaliplatin capecitabine combination) when used as first line therapy for MGC patients.BackgroundDocetaxel, platin...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Xiao-Yin Zhao, Xin Liu, Wen-Hua Li, Li-Xin Qiu, Ming-Zhu Huang, Chen-Chen Wang, Zhi-Yu Chen, Wen Zhang, Wan-Jing Feng, Wei-Jian Guo, Xiaodong Zhu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-10-01
Serie:	Frontiers in Oncology
Soggetti:	Stomach neoplasm (gastric cancer) chemotherapy docetaxel (DOC) capecitabine oxaliplatin (L-OHP)
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.911160/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!